Thanks for the efforts of our distributors all over the world. Although COVID-19 crushes the world economy, BiOptic is still growing while facing this pandemic. Due to the increasing number of orders, our production efficiency almost reaches its limit, so we decided to enlarge the space of our production line to fulfill the market demand. The headquarter of BiOptic Inc. will be relocated to the next building beside our existing ones from 12/19 to 12/20.
BiOptic Inc. won A+ Industrial Innovation R&D Program
2020-11-13
The winner of A+ Industrial Innovation R&D Program has been announced a few days ago. Based on our breakthrough technology and R&D Vision and Directions, BiOptic Inc. was finally selected by the committee and received the subsidies after several rounds of competition between many outstanding manufacturers throughout the world. Perhaps, the growing market share of BiOptic's products in over 50 countries might also be part of the winning factors.
SPECIAL ANNOUNCEMENT
For gathering every distributor/partner around the world together and letting BiOptic to share more information about our new products and functions under the threat of COVID-19, BiOptic will have our 2020 distributor meeting as a Web Conference!
2020 BiOptic Inc. Summer Internship Activity Started!
2020-08-01
BiOptic Inc. has won the 2020 Taipei Biotechnology Award for Innovative Technology Award, which is definitely the result of the hard work of all employees of BiOptic Inc..
BiOptic Inc.'s Alzheimer's disease genotype screening kit (RUO, Research Use Only) can be used with BiOptic Inc.'s main product-Electrophoresis Nucleic Acid Fragment Analyzer for back-end analysis.
Have you ever heard about the "Portable Infectious Diseases Detection Platform "? This platform can eliminate the time for sample transportation and reduce disease spreading risk, which is a powerful tool for disease control on Border or Swarm infection hot spots inspection.
